Sort
82,697 grants matching “vaccine development”
IGF::OT::IGF NIAID PRECLINICAL DEVELOPMENT SUPPORT - PRODUCTION OF A CHIMPANZEE ADENOVIRUS HIV-1 VACCINE
$1,880,590Phillip Ishikawa · Advanced Bioscience Laboratories, Inc. · N01 · FY2016 · AI
Project 1: Enabling innate-adaptive immune crosstalk by improving NK cell trafficking and resistance to suppression
$1,879,957Dean A Lee · Research Inst Nationwide Children'S Hosp · U54 · FY2019 · CA
National Resource for Automated Molecular Microscopy
$1,879,865Bridget Olivia Carragher · New York Structural Biology Center · P41 · FY2017 · GM
EFFICACY OF DNA AND PROTEIN CO-IMMUNIZATION PROTOCOL TO PROTECT MACAQUES FORM SHIV INFECTION
$1,879,802Marx Preston · Tulane University Of Louisiana · N01 · FY2014 · AI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,879,702Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2020 · AI
T Cell Memory to Pathogens: Generation and Function
$1,878,934Susan L Swain · Univ Of Massachusetts Med Sch Worcester · P01 · FY2012 · AI
Center for Biologically Inspired Nano-scaffolds for Mitigating Chlamydia trachomatis Pathogenesis
$1,878,172Matthew Adrian Coleman · Lawrence Livermore National Security, Llc · U19 · FY2023 · AI
Nonhuman Primate (NHP) Core Cellular Immunology Laboratory for AIDS Vaccine Research Development
$1,877,705Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2022 · AI
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$1,877,496Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2021 · AI
The Miami Center for AIDS Research
$1,877,373Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2013 · AI
SPORE in Prostate Cancer
$1,877,328William George Nelson · Johns Hopkins University · P50 · FY2014 · CA
Modulation of Biodefense Responses to Microbial Pathogens
$1,877,158Leo Lefrancois · University Of Connecticut Sch Of Med/Dnt · P01 · FY2009 · AI
Viral genomics: comprehensive detection, transmission inference, and functional characterization
$1,876,974Pardis Christine Sabeti · Broad Institute, Inc. · U19 · FY2024 · AI
HIV VACCINE CLINICAL TRIALS UNIT
$1,876,165Vanderbilt University · U01 · FY2003 · AI
Protein homeostasis mechanisms underlying enterovirus replication and evolution
$1,875,346Raul Andino · University Of California, San Francisco · P01 · FY2015 · AI
Enhancing T Cell Therapy of Cancer
$1,874,319Helen E Heslop · Baylor College Of Medicine · P01 · FY2014 · CA
Serious Hazards of Transfusion & Cellular Therapies: Mechanisms and Intervention
$1,874,127Christopher D Hillyer · Emory University · P01 · FY2008 · HL
Non-Invasive Plant Virus Particle-Based Anthrax Vaccines
$1,872,449Dow Chemical Company · U01 · FY2004 · AI
Prevention of AIDS
$1,872,396Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
The Ohio State University AIDS Clinical Trials Unit
$1,871,585Susan L Koletar · Ohio State University · UM1 · FY2012 · AI
Noroviruses and Epidemic Gastroenteritis
$1,871,553Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Comparison of Dendritic Cell-Based Therapeutic Vaccine Strategies for HIV Functional Cure
$1,871,420Sharon Riddler · University Of Pittsburgh At Pittsburgh · U01 · FY2018 · AI
SPORE In Prostate Cancer
$1,871,390Howard I Scher · Sloan-Kettering Inst Can Research · P50 · FY2013 · CA
Development of Fludase as an Anti-Influenza Agent
$1,871,371Mang Yu · Nexbio, Inc. · U01 · FY2006 · AI
Reagent Resource Support Program for AIDS Vaccine Development
$1,871,237Ronald Brown · Quality Biological, Inc. · N01 · FY2017 · AI